Epstein Secrets

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

ey have in two months." CBS' Mola Lenghi added, "Twenty states plus DC and Puerto Rico are reporting increases from new cases from two weeks ago." Tom Costello of NBC Nightly News <https://playvideo.bul letinintel I igence. corn/1 IT83 da53 ac44225b067701ac6f8321 a?pubid=fbi> (9/22, story 3, 2:55, Holt, 5.

-covid- vaccine-trial-in-days?smd=premium> (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 EFTA00137117 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

nt. On NBC Nightly News <https://playvideo.bulletinintelligence.comTheda8ce4e804a7f90ale70576d7c496? pubid=fbi> (11/11, story 3, 1:45, Holt, 5.8M), Tom Costello reported, "Receiving emergency FDA approval, Eli Lilly's new IV antibody treatment is similar to what President Trump received last month. Meant for

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

med insufficiently loyal." FDA Grants Emergency Approval To Eli Lilly Antibody Treatment. On NBC Nightly NewsVI (11/11, story 3, 1:45, Holt, 5.8M), Tom Costello reported, "Receiving emergency FDA approval, Eli Lilly's new IV antibody treatment is similar to what President Trump received last month. Meant fo

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

ey have in two months." CBS' Mola Lenghi added, "Twenty states plus DC and Puerto Rico are reporting increases from new cases from two weeks ago." Tom Costello of NBC Nightly NewsVi (9/22, story 3, 2:55, Holt, 5.78M) reported that "17 states plus Puerto Rico report a disturbing increase in coronavirus cases

starting Monday." Bloomberg adds that according to Mkhize, "the government will start a mass vaccination effort at 87 sites across the country using Pfizer Inc. doses administered to frontline health-care workers and the elderly." Pandemic Leading To Refugee Waves Across World. The New York Times (5/16, Jo

reducing it by half in some cases." FTC Warns About Cryptocurrency Scams. On NBC Nightly NewsVi (5/14, story 8, 1:40, Holt, 4.72M), correspondent Tom Costello reported that "digital cryptocurrencies have exploded in value and popularity with many Americans eager to get in on the action. But federal invest

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

ey have in two months." CBS' Mola Lenghi added, "Twenty states plus DC and Puerto Rico are reporting increases from new cases from two weeks ago." Tom Costello of NBC Nightly NewsVi (9/22, story 3, 2:55, Holt, 5.78M) reported that "17 states plus Puerto Rico report a disturbing increase in coronavirus cases

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

med insufficiently loyal." FDA Grants Emergency Approval To Eli Lilly Antibody Treatment. On NBC Nightly NewsVI (11/11, story 3, 1:45, Holt, 5.8M), Tom Costello reported, "Receiving emergency FDA approval, Eli Lilly's new IV antibody treatment is similar to what President Trump received last month. Meant fo